Patents by Inventor Hans Yssel

Hans Yssel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antimicrobial peptides of the cecropin family and therapeutic uses thereof
    Patent number: 8697637
    Abstract: The present invention relates to an antimicrobial peptide characterised in that said peptide includes the sequence SEQ ID No. 1 or the sequence SEQ ID No. 2, the sequence SEQ ID No. 2 representing a fragment of the sequence SEQ ID No. 1, for use as a drug. Advantageously according to the invention, the peptide having sequence SEQ ID No. 1 is used specifically for treating bacterial, viral and/or parasitic infections, and the peptide having sequence SEQ No. 2 is used for treating bacterial and/or viral infections.
    Type: Grant
    Filed: February 3, 2011
    Date of Patent: April 15, 2014
    Assignee: Institut de Recherche pour le Developpement (IRD)
    Inventors: Marthe Dorothée Misse Brumas, Natthanej Luplertlop, Hans Yssel, Frédéric Thomas, François Renaud
  • ANTIMICROBIAL PEPTIDES OF THE CECROPIN FAMILY AND THERAPEUTIC USES THEREOF
    Publication number: 20120316102
    Abstract: The present invention relates to an antimicrobial peptide characterised in that said peptide includes the sequence SEQ ID No. 1 or the sequence SEQ ID No. 2, the sequence SEQ ID No. 2 representing a fragment of the sequence SEQ ID No. 1, for use as a drug. Advantageously according to the invention, the peptide having sequence SEQ ID No. 1 is used specifically for treating bacterial, viral and/or parasitic infections, and the peptide having sequence SEQ No. 2 is used for treating bacterial and/or viral infections.
    Type: Application
    Filed: February 3, 2011
    Publication date: December 13, 2012
    Applicant: Institut de Recherche pour le Development (IRD)
    Inventors: Marthe Dorothée Misse Brumas, Natthanej Luplertlop, Hans Yssel, Frédéric Thomas, François Renaud
  • METHODS OF USING IL-21
    Publication number: 20100291029
    Abstract: An allelic variation in the IL-21 receptor can result in reduced IFN-? production in individuals and can require administration of different doses of IL-21 to achieve therapeutic effects seen individuals that do not have the allelic variant. Based on the genotype of a patient's IL-21 receptor allele, methods of predicting therapeutic response to treatment with IL-21 are disclosed. Also disclosed are methods of selecting a therapeutic regimen for use of IL-21 in patients with variant IL-21 receptor alleles.
    Type: Application
    Filed: June 17, 2010
    Publication date: November 18, 2010
    Inventors: Hans Yssel, Laurence Guglielmi, Jérôme Pène
  • METHODS OF USING IL-21
    Publication number: 20070111239
    Abstract: An allelic variation in the IL-21 receptor can result in reduced IFN-? production in individuals and can require administration of different doses of IL-21 to achieve therapeutic effects seen individuals that do not have the allelic variant. Based on the genotype of a patient's IL-21 receptor allele, methods of predicting therapeutic response to treatment with IL-21 are disclosed. Also disclosed are methods of selecting a therapeutic regimen for use of IL-21 in patients with variant IL-21 receptor alleles.
    Type: Application
    Filed: September 22, 2006
    Publication date: May 17, 2007
    Inventors: Hans Yssel, Laurence Guglielmi, Jerome Pene